MX348467B - Proceso para la preparación de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina. - Google Patents

Proceso para la preparación de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina.

Info

Publication number
MX348467B
MX348467B MX2013011650A MX2013011650A MX348467B MX 348467 B MX348467 B MX 348467B MX 2013011650 A MX2013011650 A MX 2013011650A MX 2013011650 A MX2013011650 A MX 2013011650A MX 348467 B MX348467 B MX 348467B
Authority
MX
Mexico
Prior art keywords
preparation
diiodo
tyrosine
iodophenyl
compound
Prior art date
Application number
MX2013011650A
Other languages
English (en)
Other versions
MX2013011650A (es
Inventor
Lucio Anelli Pier
Boi Valeria
Cavalieri Livio
Galimberti Laura
Gazzetto Sonia
Lattuada Luciano
Maisano Federico
Rivolta Giovanni
Vella Fulvia
Argese Maria
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/083,047 external-priority patent/US20110245342A1/en
Priority claimed from IT000713A external-priority patent/ITMI20110713A1/it
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Publication of MX2013011650A publication Critical patent/MX2013011650A/es
Publication of MX348467B publication Critical patent/MX348467B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/24Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfuric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42Separation; Purification; Stabilisation; Use of additives
    • C07C303/44Separation; Purification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/04Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
    • C07C303/08Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with halogenosulfonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona a un proceso para la preparación de la sal monosódica del derivado 3,5-diiodo-O-[3-iodo-4-(sulfooxi)fenil]-L-tirosina (T3S)iniciando del compuesto fenólico correspondiente, en presencia de ácido clorosulfónico y dimetilacetamida como un solvente. El T3S así obtenido se puede aislar convenientemente en una forma pura como un sólido en producciones buenas. La presente invención además se relaciona al proceso para la preparación de T3S, en donde el reactivo de inicio es T2 y además comprende la formulación del compuesto en comprimidos. Además, la invención describe inmuno-ensayos no radioactivos con base en derivados de T3S.
MX2013011650A 2011-04-08 2012-04-05 Proceso para la preparación de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina. MX348467B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/083,047 US20110245342A1 (en) 2002-11-13 2011-04-08 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
IT000713A ITMI20110713A1 (it) 2011-04-29 2011-04-29 Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
PCT/EP2012/056274 WO2012136761A1 (en) 2011-04-08 2012-04-05 Process for the preparation of a sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine

Publications (2)

Publication Number Publication Date
MX2013011650A MX2013011650A (es) 2013-11-01
MX348467B true MX348467B (es) 2017-06-13

Family

ID=45929531

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011650A MX348467B (es) 2011-04-08 2012-04-05 Proceso para la preparación de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina.

Country Status (13)

Country Link
EP (3) EP3260443B1 (es)
JP (3) JP5833222B2 (es)
KR (2) KR101800229B1 (es)
CN (2) CN107840813B (es)
AU (3) AU2012238665B2 (es)
CA (2) CA3017729C (es)
DK (1) DK2694471T3 (es)
ES (2) ES2645295T3 (es)
IL (1) IL228757B (es)
MX (1) MX348467B (es)
RU (1) RU2610093C2 (es)
SI (1) SI2694471T1 (es)
WO (1) WO2012136761A1 (es)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993928A (en) * 1957-01-15 1961-07-25 Glaxo Lab Ltd Preparation of triiodothyronine
US2970165A (en) * 1957-10-01 1961-01-31 Warner Lambert Pharmaceutical Sulfate compounds
US3313839A (en) * 1963-07-01 1967-04-11 Gen Aniline & Film Corp Preparation of sulfate esters by the reaction of chlorosulfonic acid with alkoxylated alkyl phenols
DK0550108T3 (da) * 1991-12-30 1999-01-04 Akzo Nobel Nv Thyreoaktiv sammensætning med langvarig frigivelse
JP3487620B2 (ja) * 1992-12-01 2004-01-19 日本製粉株式会社 逆転写酵素阻害剤及び抗ウイルス剤
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
DE4441147A1 (de) * 1994-11-18 1996-05-23 Hoechst Ag Verfahren zur Herstellung von 3-(N-Aryl-amino)-propyl-2'-sulfatoethyl-sulfonyl-Verbindungen
US5955105A (en) * 1995-11-14 1999-09-21 Knoll Pharmaceutical Company Stabilized thyroid hormone preparations and methods of making same
AU2001278034A1 (en) * 2000-07-26 2002-02-05 Bio-Diagnostics Inc. Method for diagnosing thyroid conditions and for monitoring thyroxine therapy
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US6423549B1 (en) * 2001-03-14 2002-07-23 Bio-Rad Laboratories, Inc. Phycoerythrin labeled thyronine analogues and assays using labeled analogues
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
GB0215978D0 (en) * 2002-07-10 2002-08-21 Karobio Ab Novel compounds
ITMI20022394A1 (it) * 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
EP2965751A1 (en) * 2004-10-08 2016-01-13 Forward Pharma A/S Controlled release pharmaceutical compositions comprising a fumaric acid ester
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
FR2931359B1 (fr) * 2008-05-20 2012-12-21 Menvielle Bourg Fabienne Joanny Utilisation d'une matrice pour administration orale de magnesium a liberation prolongee, et composition contenant cette matrice
RU2701731C2 (ru) * 2009-04-01 2019-10-01 Биал-Портела Энд Ка, С.А. Фармацевтические препараты, содержащие производные нитрокатехина, и способы их получения

Also Published As

Publication number Publication date
JP5833222B2 (ja) 2015-12-16
RU2013149419A (ru) 2015-05-20
DK2694471T3 (da) 2017-11-13
CA3017729C (en) 2020-11-03
CA2831697C (en) 2018-10-30
EP2694471B1 (en) 2017-08-02
AU2012238665A1 (en) 2013-11-28
SI2694471T1 (sl) 2017-12-29
CA3017729A1 (en) 2012-10-11
EP3260443B1 (en) 2020-10-07
KR101865883B1 (ko) 2018-06-08
ES2645295T3 (es) 2017-12-04
KR101800229B1 (ko) 2017-12-20
KR20170070280A (ko) 2017-06-21
AU2012238665B2 (en) 2016-09-29
EP3736264A1 (en) 2020-11-11
EP2694471A1 (en) 2014-02-12
AU2016265998A1 (en) 2016-12-15
JP2016048244A (ja) 2016-04-07
KR20140027220A (ko) 2014-03-06
IL228757B (en) 2018-07-31
CN103534232A (zh) 2014-01-22
CN107840813B (zh) 2020-12-22
JP2014516354A (ja) 2014-07-10
IL228757A0 (en) 2013-12-31
JP2017214391A (ja) 2017-12-07
ES2929462T3 (es) 2022-11-29
EP3736264B1 (en) 2022-08-24
WO2012136761A1 (en) 2012-10-11
RU2610093C2 (ru) 2017-02-07
JP6166762B2 (ja) 2017-07-19
AU2018206768A1 (en) 2018-08-09
AU2018206768B2 (en) 2019-08-22
AU2016265998B2 (en) 2018-07-05
EP3260443A1 (en) 2017-12-27
CN107840813A (zh) 2018-03-27
CA2831697A1 (en) 2012-10-11
JP6389927B2 (ja) 2018-09-12
MX2013011650A (es) 2013-11-01

Similar Documents

Publication Publication Date Title
CY1117915T1 (el) Συγχωνευμενες βενζοξαζεπινονες ως διαμορφωτες διαυλων ιοντων
AU2013380573A8 (en) A process for sodium salt of (2S, 5R)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane
CA2875877C (en) Syk inhibitors
MX2016006336A (es) Compuestos pirazolopirimidina.
MX350892B (es) Síntesis de compuesto antiviral.
AR085155A1 (es) Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen dichos compuestos
MA35664B1 (fr) Nouveaux dérivés bicycliques de la dihydroisoquinoline-1-one
EA201591527A1 (ru) Новые производные пиридина
RS51210B (sr) Dobijanje pregaballina i srodnih jedinjenja
NZ711343A (en) Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation
WO2014120861A3 (en) Method off preparing oligomeric compounds
CA2899024C (en) Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
PT2462098E (pt) Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
IN2014DN00144A (es)
EA201490998A1 (ru) Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
IN2014DN05972A (es)
BR102014005754B8 (pt) composto,e, método para a preparação de um composto
MX364766B (es) Proceso para la preparacion de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina.
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
WO2011157388A8 (en) Process for the preparation of pteridine derivatives
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
MX348467B (es) Proceso para la preparación de un derivado sulfatado de 3,5-diiodo-o-[3-iodofenil]-l-tirosina.
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.

Legal Events

Date Code Title Description
FG Grant or registration